Biotech firms offer low-cost vaccines to health NGO GAVI

Serum Institute, and have independently agreed to supply pentavalent and rotavirus vaccines for infants at discounted rates to global health NGO GAVI Alliance.

As a result, each pentavalent vaccine, which combines five different vaccines in one, will be available for $1.75 (Rs 78) a dose, while a rotavirus vaccine will cost $3 (Rs 134) for full course.

“Serum, which had already lowered its price to $1.75 per dose, the lowest price available today, announced it would continue to provide the most competitive pricing and encouraged other manufacturers to follow its lead. Panacea Biotec committed to lower its prices by up to 15 per cent,” a GAVI press release said.

The pentavalent vaccine protects against five potential killers: diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b. Rotavirus is the leading cause of severe diarrhoea — the world’s second-biggest killer of children after pneumonia.

GAVI said Bharat Biotech’s offer of immunising a child against rotavirus for $3 can happen only by 2015 as the company, along with and Shantha Biotechnics, a subsidiary of Sanofi Pasteur, are yet to commercialise the vaccine. UNICEF, which procures the majority of vaccines funded by GAVI, was conducting a tender for rotavirus vaccines. It would assess offers from manufacturers in the coming months, the GAVI statement said.

According to Helen Evans, GAVI’s interim CEO, if each rotavirus vaccine could be purchased this year at $2.50, the impact on public health could be significant and would allow GAVI to save approximately $500 million till 2020, or about $140 million till 2015, as measured against GAVI’s current financial estimates.

GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries.

image
Business Standard
177 22
Business Standard

Biotech firms offer low-cost vaccines to health NGO GAVI

Bs Reporter  |  New Delhi 



Serum Institute, and have independently agreed to supply pentavalent and rotavirus vaccines for infants at discounted rates to global health NGO GAVI Alliance.

As a result, each pentavalent vaccine, which combines five different vaccines in one, will be available for $1.75 (Rs 78) a dose, while a rotavirus vaccine will cost $3 (Rs 134) for full course.

“Serum, which had already lowered its price to $1.75 per dose, the lowest price available today, announced it would continue to provide the most competitive pricing and encouraged other manufacturers to follow its lead. Panacea Biotec committed to lower its prices by up to 15 per cent,” a GAVI press release said.

The pentavalent vaccine protects against five potential killers: diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b. Rotavirus is the leading cause of severe diarrhoea — the world’s second-biggest killer of children after pneumonia.

GAVI said Bharat Biotech’s offer of immunising a child against rotavirus for $3 can happen only by 2015 as the company, along with and Shantha Biotechnics, a subsidiary of Sanofi Pasteur, are yet to commercialise the vaccine. UNICEF, which procures the majority of vaccines funded by GAVI, was conducting a tender for rotavirus vaccines. It would assess offers from manufacturers in the coming months, the GAVI statement said.

According to Helen Evans, GAVI’s interim CEO, if each rotavirus vaccine could be purchased this year at $2.50, the impact on public health could be significant and would allow GAVI to save approximately $500 million till 2020, or about $140 million till 2015, as measured against GAVI’s current financial estimates.

GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries.

RECOMMENDED FOR YOU

Biotech firms offer low-cost vaccines to health NGO GAVI

Biotech firms Serum Institute, Panacea Biotec and Bharat Biotech have independently agreed to supply pentavalent and rotavirus vaccines for infants at discounted rates to global health NGO GAVI Alliance.

Serum Institute, and have independently agreed to supply pentavalent and rotavirus vaccines for infants at discounted rates to global health NGO GAVI Alliance.

As a result, each pentavalent vaccine, which combines five different vaccines in one, will be available for $1.75 (Rs 78) a dose, while a rotavirus vaccine will cost $3 (Rs 134) for full course.

“Serum, which had already lowered its price to $1.75 per dose, the lowest price available today, announced it would continue to provide the most competitive pricing and encouraged other manufacturers to follow its lead. Panacea Biotec committed to lower its prices by up to 15 per cent,” a GAVI press release said.

The pentavalent vaccine protects against five potential killers: diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b. Rotavirus is the leading cause of severe diarrhoea — the world’s second-biggest killer of children after pneumonia.

GAVI said Bharat Biotech’s offer of immunising a child against rotavirus for $3 can happen only by 2015 as the company, along with and Shantha Biotechnics, a subsidiary of Sanofi Pasteur, are yet to commercialise the vaccine. UNICEF, which procures the majority of vaccines funded by GAVI, was conducting a tender for rotavirus vaccines. It would assess offers from manufacturers in the coming months, the GAVI statement said.

According to Helen Evans, GAVI’s interim CEO, if each rotavirus vaccine could be purchased this year at $2.50, the impact on public health could be significant and would allow GAVI to save approximately $500 million till 2020, or about $140 million till 2015, as measured against GAVI’s current financial estimates.

GAVI Alliance is a Geneva-based public-private partnership aimed at improving health in the world’s poorest countries.

image
Business Standard
177 22
Widgets Magazine

More News

  • Ajei Gopal Indian-origin software industry veteran Ajei Gopal named CEO of US firm
  • Tata Sons reaches for the sky, infuse more funds in Vistara, Air Asia Tata Sons reaches for the sky, infuses more funds in Vistara, AirAsia
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard